ABVC BioPharma share price logo

ABVC BioPharma

NASDAQ: ABVC

$0.86

+0.01

(+1.58%)

as on

ABVC BioPharma Stock Performance

as on August 19, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.82
    $0.90
    downward going graph

    5.02%

    Downside

    4.25%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.86
    $3.40
    downward going graph

    0.75%

    Downside

    293.84%

    Upside

    downward going graph

ABVC BioPharma share price movements today

Previous Close
$0.85
Open
$0.84
Volume
183.6K
Market Cap
$23.4M
Day's Low - High
$0.82 - $0.90
52 Week Low - High
$0.86 - $3.40

ABVC BioPharma Historical Returns

1 Month Return
-28.01 %
3 Month Return
-17.44 %
1 Year Return
-72.73 %
3 Year Return
-50.01 %
5 Year Return
-95.78 %

ABVC BioPharma Stock Fundamentals & Key Indicators

Check ABVC BioPharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.4M

EPS (TTM)

-0.0149

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.25

Industry PE ratio

-1.5966015625

PEG Ratio

0.04660119151136646

EBITDA

-7.8M

Revenue (TTM)

-796.0K

Profit Margin

100.00%

Return On Equity TTM

-71.47%

ABVC BioPharma Stock Valuation

Track how ABVC BioPharma P/E has moved over time to understand its valuation trends.

ABVC BioPharma in the last 5 years

  • Overview

  • Trends

Lowest (-6.62x)

March 31, 2022

Today (-5.46x)

December 31, 2025

Industry (-1.60x)

December 31, 2025

Highest (-0.65x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -5.46x

ABVC BioPharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ABVC BioPharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
ABVC BioPharma image
ABVC BioPharma
SELL$23.4M-95.78%-3.25100.00%NA
Revolution Medicines image
Revolution Medicines
BUY$43.7B669.3%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$128.2B154.86%29.8286.04%NA
Regeneron image
Regeneron
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for ABVC BioPharma Stock including INR - Dollar returns

The ABVC BioPharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

ABVC BioPharma investment value today

Current value as on today

₹28,665

Returns

-₹71,335

(-71.33%)

Returns from ABVC BioPharma Stock

-₹73,839 (-73.84%)

Dollar Impact

₹2,505 (+2.5%)

Analyst Recommendation on ABVC BioPharma Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for ABVC BioPharma. Average target price of $2.02

ABVC BioPharma Share Price Target

Get share price movements and forecasts by analysts on ABVC BioPharma.

What analysts predicted

57.26%UPSIDE

Target Price

$2.02

Current Price

$0.8633

Analyzed by

6 Analysts

Target

$2.02

ABVC BioPharma target price $2.02, a slight upside of 57.26% compared to current price of $0.8633. According to 6 analysts rating.

Indian Investors' Interest in ABVC BioPharma Stock

Search interest for ABVC BioPharma Stock has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-43% versus previous 30 day period

ABVC BioPharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
-
-
-
0
-
-
Gross Profit
0
0
0
0
-
-
-
0
-
-
Operating Income
-2
0
0
0
0
-2
-1
-2
-1
0
EBITDA
-2
0
0
0
0
-2
-1
-3
-1
0
Interest Expense
0
0
0
-
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-2
-1
0
0
0
-2
-2
-3
-1
0
Income Tax Expense
-
0
0
-
-
0
0
-
-
0
Net Income
-2
0
0
0
0
-2
-2
-3
-1
0
Net Profit Margin
77.01%
99.84%
99.92%
100.00%
0.00%
0.00%
0.00%
100.00%
0.00%
0.00%

ABVC BioPharma Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Mar 2022
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
0
0
0
0
0
0
-
Gross Profit
-
0
0
0
0
0
0
0
-
Operating Income
-4
-2
-3
-8
-11
-15
-6
-4
-7
EBITDA
-4
-5
-3
-10
-10
-15
-6
-4
-7
Interest Expense
0
0
0
0
0
0
1
0
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-6
-4
-10
-11
-15
-8
-5
-8
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
-4
-5
-3
-9
-12
-16
-7
-4
-7
Net Profit Margin
0.00%
-3190.54%
97.13%
96.13%
98.57%
70.47%
-98.15%
99.85%
0.00%

ABVC BioPharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
0
0
0
0
-2
-1
-3
-1
0
Operating Cash Flow
0
0
0
0
0
0
0
-1
0
0
Investing Cash Flow
-
0
-
-
-
0
-1
0
0
0
Financing Cash Flow
0
0
0
0
0
1
1
1
0
0
Change in Cash
0
0
0
0
0
0
0
0
-1
-

ABVC BioPharma Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Mar 2022
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Net Income
-6
-4
-3
-10
-12
-16
-7
-5
-8
Operating Cash Flow
-1
0
-3
-4
-7
-7
-4
-1
-2
Investing Cash Flow
-7
0
0
0
0
-1
0
-
-1
Financing Cash Flow
9
0
3
9
9
4
3
1
4
Change in Cash
0
0
0
4
1
-5
0
0
0

Mutual Funds that own ABVC BioPharma Stock

Check out the Mutual Funds with significant holdings in ABVC BioPharma.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
0.717674%
190574
Fidelity Concord Street Trust
0.641163%
170257

Global Institutional Holdings in ABVC BioPharma

Funds
Holdings
Vanguard
1.41%

Insights on ABVC BioPharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -3.56M → -736.93K (in $), with an average increase of 120.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 615.7% return, outperforming this stock by 670.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 481.6% return, outperforming this stock by 554.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 795.95K → -795.95K (in $), with an average decrease of 200.0% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ABVC stock has moved down by -13.7%

About ABVC BioPharma

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus, which is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer; ABV-2001, an intraocular irrigation solution; ABV-2002, a corneal Storage Solution; and ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer. The company has a co-development agreement with Rgene Corporation and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California.
OrganisationABVC BioPharma
Headquarters44370 Old Warm Springs Boulevard, Fremont, CA, United States, 94538
IndustryBiotechnology
CEODr. Uttam Yashwant Patil Ph.D.
E-voting on sharesClick here to vote

Key Management of ABVC BioPharma

Name

Title

Mr. Eugene Jiang

Chairman & Chief Business Officer

Dr. Uttam Yashwant Patil Ph.D.

CEO & Interim CFO

Dr. Tsung-Shann Jiang EMBA, Ph.D.

Chief Scientific Officer, Chief Strategy Officer & Director

FAQs

What is ABVC BioPharma share price today?

ABVC BioPharma share price today is $0.86 as on at the close of the market. ABVC BioPharma share today touched a day high of $0.90 and a low of $0.82.

What is the 52 week high and 52 week low for ABVC BioPharma share?

ABVC BioPharma share touched a 52 week high of $3.40 on and a 52 week low of $0.86 on . ABVC BioPharma stock price today i.e. is closed at $0.86,which is 74.61% down from its 52 week high and 0.76% up from its 52 week low.

What is ABVC BioPharma's market capitalisation today?

ABVC BioPharma market capitalisation is $0.00T as on .

How to invest in ABVC BioPharma Stock (ABVC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ABVC BioPharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ABVC BioPharma Shares that will get you 1.7375 shares as per ABVC BioPharma share price of $0.86 per share as on August 19, 2026 at 1:29 am IST.

What is the minimum amount required to buy ABVC BioPharma Stock (ABVC) from India?

Indian investors can start investing in ABVC BioPharma (ABVC) shares with as little as ₹95.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.70 in ABVC BioPharma stock (as per the Rupee-Dollar exchange rate as on ). Based on ABVC BioPharma share’s latest price of $0.86 as on August 19, 2026 at 1:29 am IST, you will get 11.5835 shares of ABVC BioPharma. Learn more about fractional shares .

What are the returns that ABVC BioPharma has given to Indian investors in the last 5 years?

ABVC BioPharma stock has given -95.78% share price returns and 28.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?